Listed

Mettler Toledo International Inc/: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Jul 31, 2020 and accepted by EDGAR at Jul 31, 2020, 09:01 ET.

Share

Management's discussion and analysis

As filed, 34,714 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.

General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and six months ended June 30, 2020 are not necessarily indicative of the results to be expected for the full year ending December 31, 2020.

Changes in local currency exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.

COVID-19

The 2019 Coronavirus (COVID-19) pandemic has resulted in millions of confirmed cases throughout the world and in all countries where we conduct business. The outbreak has caused many governments to implement stay-at-home orders, quarantines and significant restrictions on travel. Several governments have also implemented work restrictions that prohibit many employees from going to their customary work locations and which require these employees to work remotely if possible. The quarantines, travel bans, work and other restrictions were initially put in place on a national level in China in January 2020, and with the global spread of the virus, subsequently adopted in other countries and regions during the first quarter of 2020 with many restrictions commencing in Asia Pacific, Europe, North America, and South America. Many of these restrictions remained in place during the second quarter of 2020.

The health and safety of our employees and business partners has been our highest priority throughout the COVID-19 pandemic, and we have implemented several preventative and protective measures relating to social distancing, hygiene, health monitoring, personal protective equipment, split shifts and remote work. We have also implemented business continuity plans and have been able to continue to support our customers with their essential businesses such as in life sciences, food manufacturing, chemicals (e.g. sanitizers, disinfectants, soaps etc.), food retail and transportation and logistics. Our production and logistics facilities are currently operational, and our office-based employees have been able to work remotely in adherence to applicable jurisdictional stay-at-home orders. Our supply chain is currently continuing with minimal interruption, and we currently maintain adequate product inventory levels and safety stock for certain components. We quickly adapted to leverage our digital and remote sales and service capabilities, while also meeting delivery requirements with our global supply chain. Our service organization also continues to provide on-site and remote customer support to facilitate uptime, productivity and regulatory compliance.

We have also implemented various temporary cost containment measures related to workforce management and discretionary spending. Our workforce management measures primarily include reduced work hours, salary freezes, and voluntary senior leadership salary reductions.

We maintain adequate liquidity consisting of approximately $712.1 million of additional borrowings available under our Credit Agreement, and $127.3 million of cash and cash equivalents as of June 30, 2020.

As further described in the Risk Factors section of this Form 10-Q, COVID-19 presents several risks to our business. For example, businesses can be shutdown, supply chains can be interrupted, slowed, or rendered inoperable, and individuals can become ill, quarantined, or otherwise unable to work and/or travel due to health reasons or governmental restrictions. COVID-19 also interferes with general commercial activity related to our supply chain and customer base. In addition, it is expected that COVID-19 will negatively affect the global economy and our customers' businesses, which will likely result in delayed or reduced purchases from us. Some customers may also have difficulty meeting their payment obligations to us, resulting in late payments or an inability of some customers to make payments at all.

During the six months ended June 30, 2020, COVID-19 had a negative impact on our business, primarily related to reduced customer demand in all regions. We remain cautious as uncertainties related to COVID-19 and the resulting impact to the economy continues in all regions of the world and market conditions may also change quickly. With the global spread of the virus and related negative impact to the global economy, we expect reduced global sales volume due to lower customer demand in future quarters. The longer-term effects on our business will be impacted by the global economy and any recession implications in different regions of the world. While it is extremely difficult to estimate the extent and duration of any COVID-19 implications, the effects on our business, results of operations and financial condition could be material.

Results of Operations – Consolidated

The following tables set forth certain items from our interim consolidated statements of operations for the three and six month periods ended June 30, 2020 and 2019 (amounts in thousands).

Three months ended June 30, 2020 (unaudited)% 2019 (unaudited)% Six months ended June 30, 2020 (unaudited)% 2019 (unaudited)%
Net sales $690,673 100.0 $731,366 100.0 $1,339,835 100.0 $1,410,818 100.0
Cost of sales 292,703 42.4 311,828 42.6 567,456 42.4 602,961 42.7
Gross profit 397,970 57.6 419,538 57.4 772,379 57.6 807,857 57.3
Research and development 31,193 4.5 36,582 5.0 65,580 4.9 72,635 5.1
Selling, general and administrative 190,134 27.5 205,215 28.1 388,878 29.0 409,640 29.0
Amortization 13,889 2.0 12,326 1.7 27,887 2.1 24,548 1.7
Interest expense 9,582 1.4 8,882 1.2 19,801 1.5 17,976 1.4
Restructuring charges 860 0.1 2,891 0.4 2,765 0.2 4,414 0.3
Other charges (income), net (2,943) (0.4) (1,574) (0.2) (6,286) (0.5) (2,248) (0.1)
Earnings before taxes 155,255 22.5 155,216 21.2 273,754 20.4 280,892 19.9
Provision for taxes 28,693 4.2 28,056 3.8 49,077 3.7 41,927 3.0
Net earnings $126,562 18.3 $127,160 17.4 $224,677 16.8 $238,965 16.9

Net sales

Net sales were $690.7 million and $731.4 million for the three months ended June 30, 2020, and 2019, and $1.3 billion and $1.4 billion for the six months ended June 30, 2020 and 2019, respectively. This represents a decrease of 6% and 5% in U.S. dollars for the three and six months ended June 30, 2020. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales decreased 4% and 3% for the three and six months ended June 30, 2020. Net sales for the six months ended June 30, 2020 were negatively impacted by the COVID-19 pandemic and related reduction in global customer demand on our operations. While we saw increased business activity in China during the three months ended June 30, 2020 that benefited from increased customer demand and the easing of governmental restrictions as a result of COVID-19, we remain cautious as uncertainties relating to COVID-19 and the global economy continue and market conditions may change quickly. We expect net sales in local currencies will be adversely affected by the COVID-19 pandemic related to unfavorable economic conditions and reduced customer demand in future quarters.

Net sales by geographic destination for the three and six months ended June 30, 2020 in U.S. dollars decreased in the Americas 8% and 3%, in Europe 6% and 7% and in Asia/Rest of World 2% and 6%, respectively. Our net sales by geographic destination for the three months ended June 30, 2020 in local currencies decreased in the Americas 7%, in Europe 5% and increased 1% in Asia/Rest of World, respectively. Net sales by geographic destination for the six months ended June 30, 2020 in local currencies decreased in the Americas 2%, in Europe 5% and in Asia/Rest of World 3%, respectively. Net sales in Asia/Rest of World in local currency for the three months ended June 30, 2020 includes local currency growth in China of 8% that benefited from increased customer demand and the easing of governmental restrictions as a result of COVID-19. A discussion of sales by operating segment is included below.

As described in Note 19 to our consolidated financial statements for the year ended December 31, 2019, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products decreased 5% in U.S. dollars and 3% in local currencies for the three months ended June 30, 2020 and decreased 6% in U.S. dollars and 4% in local currencies for the six months ended June 30, 2020, compared to the corresponding periods in 2019. Service revenue (including spare parts) decreased by 7% in U.S. dollars and 6% in local currencies for the three months ended June 30, 2020 and decreased 2% in U.S. dollars and 1% in local currencies for the six months ended June 30, 2020, compared to the corresponding periods in 2019.

Net sales of our laboratory products and services, which represented approximately 54% of our total net sales decreased 5% in U.S. dollars and 4% in local currencies for the three months ended June 30, 2020, and decreased 3% in U.S. dollars and 2% in local currencies for the six months ended June 30, 2020. The local currency decrease in net sales of our laboratory-related products reflects reduced customer demand, which was negatively impacted by laboratory closures due to COVID-19, offset in part by growth in process analytics, automated chemistry and pipettes.

Net sales of our industrial products and services, which represented approximately 40% of our total net sales decreased 5% in U.S. dollars and 3% in local currencies for the three months ended June 30, 2020, and decreased 6% in U.S. dollars and 4% in local currencies for the six months ended June 30, 2020. The local currency decrease in net sales of our industrial-related products for the three and six months ended June 30, 2020 includes declines in product inspection and certain core industrial product categories, offset in part by strong growth in transportation and logistics project activity. China also experienced increased business activity that benefited from increased customer demand and the easing of governmental restrictions as a result of COVID-19.

Net sales in our food retailing products and services, which represented approximately 6% of our total net sales decreased 13% in U.S. dollars and 11% in local currencies for the three months ended June 30, 2020, and decreased 15% in U.S. dollars and 14% in local currencies for the six months ended June 30, 2020. The decline in food retailing is primarily due to challenging market conditions.

Gross profit

Gross profit as a percentage of net sales was 57.6% and 57.4% for the three months ended June 30, 2020 and 2019, respectively and 57.6% and 57.3% for the six months ended June 30, 2020 and 2019, respectively.

Gross profit as a percentage of net sales for products was 59.6% and 59.9% for the three months ended June 30, 2020 and 2019, respectively, and 60.2% and 59.9% for the six months ended June 30, 2020 and 2019, respectively.

Gross profit as a percentage of net sales for services (including spare parts) was 50.7% and 48.6% for the three months ended June 30, 2020 and 2019, respectively, and 49.3% and 48.2% for the six months ended June 30, 2020 and 2019, respectively.

The increase in gross profit as a percentage of net sales for the three and six months ended June 30, 2020 primarily reflects benefits from temporary cost savings measures, favorable price realization and material cost reductions, offset in part by reduced sales volume, higher transportation costs and unfavorable business mix.

Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales was 4.5% and 5.0% for the three months ended June 30, 2020 and 2019, and was 4.9% and 5.1% for the six months ended June 30, 2020 and 2019, respectively. Research and development expenses decreased 15% in both U.S. dollars and in local currencies for the three months ended June 30, 2020, and decreased 10% in both U.S. dollars and in local currencies for the six months ended June 30, 2020, respectively, compared to the corresponding periods in 2019. The decrease relates to the timing of project activity and benefits from our temporary cost savings measures.

Selling, general and administrative expenses as a percentage of net sales were 27.5% and 28.1% for the three months ended June 30, 2020 and 2019, and was 29.0% for both the six months ended June 30, 2020 and 2019, respectively. Selling, general and administrative expenses decreased 7% in both U.S. dollars and in local currencies for the three months ended June 30, 2020, and decreased 5% in U.S. dollars and 4% in local currencies for the six months ended June 30, 2020. The local currency decrease includes benefits from our temporary and ongoing cost savings initiatives and lower cash incentive expense.

Amortization, interest expense, other charges (income), net and taxes

Amortization expense was $13.9 million and $12.3 million for the three months ended June 30, 2020 and 2019, respectively, and $27.9 million and $24.5 million for the six months ended June 30, 2020 and 2019, respectively.

Interest expense was $9.6 million and $8.9 million for the three months ended June 30, 2020 and 2019, respectively, and $19.8 million and $18.0 million for the six months ended June 30, 2020 and 2019, respectively.

Other charges (income), net includes non-service pension costs (benefits), (gains) losses from foreign currency transactions and hedging activities, interest income and other items. Nonservice pension benefits was $3.0 million and $1.2 million for the three months ended June 30, 2020 and 2019, respectively, and $5.9 million and $2.3 million and for the six months ended June 30, 2020 and 2019, respectively.

Our reported tax rate was 18.5% and 18.1% during the three months ended June 30, 2020 and 2019, respectively, and 17.9% and 14.9% during the six months ended June 30, 2020 and 2019, respectively. The provision for taxes is based upon using our projected annual effective tax rate of 20.5% and 20.0% before non-recurring discrete tax items for the three and six months ended June 30, 2020 and 2019, respectively. The difference between our projected annual effective tax rate and the reported tax rate is related to the timing of excess tax benefits associated with stock option exercises.

Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 19 to our consolidated financial statements for the year ended December 31, 2019.

U.S. Operations (amounts in thousands)

Three months ended June 30, Six months ended June 30,
2020 2019% 2020 2019%
Total net sales $276,855 $294,460 (6)% $544,654 $555,256 (2)%
Net sales to external customers $249,340 $267,889 (7)% $490,750 $502,540 (2)%
Segment profit $52,581 $53,986 (3)% $97,519 $91,971 6%

Total net sales and net sales to external customers decreased 6% and 7% for the three months ended June 30, 2020 compared with the corresponding period in 2019. Total net sales and net sales to external customers both decreased 2% for the six months ended June 30, 2020 compared with the corresponding period in 2019. Net sales to external customers for the three and six months ended June 30, 2020 includes declines in most product categories, especially food retailing, offset in part by strong growth in transportation and logistics project activity. The decrease in sales to external customers reflects reduced customer demand as a result of COVID-19.

Segment profit decreased $1.4 million and increased $5.5 million for the three and six months ended June 30, 2020, respectively, compared to the corresponding periods in 2019. Segment profit during the six months ended June 30, 2020 includes benefits from our temporary cost savings measures and margin expansion initiatives, offset in part by lower net sales volume. Segment profit during the three months ended June 30, 2020 was negatively impacted by more significant declines in net sales volume.

Swiss Operations (amounts in thousands)

Three months ended June 30, 2020 2019 %1) Six months ended June 30, 2020 2019 %1)
Total net sales $171,435 $183,289 (6)% $356,180 $370,597 (4)%
Net sales to external customers $28,948 $31,358 (8)% $60,844 $64,935 (6)%
Segment profit $48,248 $48,613 (1)% $102,158 $102,135 —%

1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales decreased 6% in U.S. dollars and 10% local currency for the three months ended June 30, 2020, and decreased 4% in U.S. dollars and 7% in local currency for the six months ended June 30, 2020 compared to the corresponding periods in 2019. Net sales to external customers decreased 8% in U.S. dollars and 10% local currency for the three months ended June 30, 2020 and decreased 6% in U.S. dollars and 9% in local currency for the six months ended June 30, 2020, compared to the corresponding periods in 2019. Local currency net sales to external customers for the three and six months ended June 30, 2020 includes declines in most product categories. The decrease in sales to external customers reflects reduced customer demand as a result of COVID-19.

Segment profit decreased $0.4 million and was flat for the three and six month periods ended June 30, 2020, compared to the corresponding periods in 2019. Segment profit during the six months ended June 30, 2020 includes lower net sales volume and unfavorable foreign currency translation, offset in part by benefits from our temporary cost savings measures and the timing of research and development activity.

Western European Operations (amounts in thousands)

Three months ended June 30, 2020 2019 %1) Six months ended June 30, 2020 2019 %1)
Total net sales $188,750 $202,893 (7)% $383,789 $412,844 (7)%
Net sales to external customers $149,051 $163,681 (9)% $302,376 $329,587 (8)%
Segment profit $30,345 $22,229 37% $54,452 $47,954 14%

1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales decreased 7% in U.S. dollars and 5% in local currencies for the three months ended June 30, 2020 and decreased 7% in U.S. dollars and 4% in local currencies for the six months ended June 30, 2020, compared to the corresponding periods in 2019. Net sales to external customers decreased 9% in U.S. dollars and 7% in local currencies for the three months ended June 30, 2020, and decreased 8% in U.S. dollars and 6% in local currencies for the six months ended June 30, 2020, compared to the corresponding periods in 2019. Local currency net sales to external customers for the three and six months ended June 30, 2020 includes declines in most product categories related to lower customer demand as a result of COVID-19.

Segment profit increased $8.1 million and $6.5 million for the three and six month periods ended June 30, 2020, respectively, compared to the corresponding periods in 2019. Segment profit increased during the three and six months ended June 30, 2020 primarily due to benefits from our temporary cost savings measures and margin expansion initiatives and timing of research and development project activity, offset in part by the decline in net sales.

Chinese Operations (amounts in thousands)

Three months ended June 30, 2020 2019 %1) Six months ended June 30, 2020 2019 %1)
Total net sales $186,638 $189,027 (1)% $335,986 $367,606 (9)%
Net sales to external customers $140,907 $136,459 3% $241,506 $258,181 (6)%
Segment profit $63,955 $65,489 (2)% $109,505 $124,973 (12)%

1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales decreased 1% in U.S. dollars and increased 2% in local currency for the three months ended June 30, 2020 and decreased 9% in U.S. dollars and 5% in local currency for the six months ended June 30, 2020, compared to the corresponding periods in 2019. Net sales to external customers increased 3% in U.S. dollars and 7% in local currency by origin for the three months ended June 30, 2020 and decreased 6% in U.S. dollars and 3% in local currency during the six months ended June 30, 2020, compared to the corresponding periods in 2019. The increase in local currency net sales to external customers during the three months ended June 30, 2020 reflects growth in industrial and laboratory related products that benefited from increased customer demand and the easing of COVID-19 governmental restrictions, while net sales to external customers for the six months ended June 30, 2020 were negatively impacted by reduced customer demand as a result of COVID-19. Significant uncertainty remains relating to COVID-19 and the local Chinese economy, and market conditions may change quickly.

Segment profit decreased $1.5 million and $15.5 million for the three and six month periods ended June 30, 2020, respectively, compared to the corresponding periods in 2019. The decrease in segment profit for the three and six months ended June 30, 2020 primarily reflects the decline in total net sales as well as unfavorable foreign currency translation, offset in part by our temporary cost savings measures.

Other (amounts in thousands)

Three months ended June 30, 2020 2019 %1) Six months ended June 30, 2020 2019 %1)
Total net sales $123,302 $133,313 (8)% $246,130 $258,170 (5)%
Net sales to external customers $122,427 $131,979 (7)% $244,359 $255,575 (4)%
Segment profit $13,122 $14,300 (8)% $24,148 $27,487 (12)%

1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales decreased 8% in U.S. dollars and 4% in local currencies for the three months ended June 30, 2020 and decreased 5% in U.S. dollars and 2% in local currencies for the six months ended June 30, 2020, compared to the corresponding periods in 2019. Net sales to external customers decreased 7% in U.S. dollars and 4% in local currencies for the three months ended June 30, 2020 and decreased 4% in U.S. dollars and 2% in local currencies for the six months ended June 30, 2020, compared to the corresponding periods in 2019.The decrease in net sales to external customers reflects reduced customer demand as a result of COVID-19.

Segment profit decreased $1.2 million and $3.3 million for the three and six months ended June 30, 2020, respectively, compared to the corresponding periods in 2019. The decrease in segment profit for the three and six months ended June 30, 2020 primarily reflects the decline in net sales as well as unfavorable foreign currency translation, offset in part by our temporary cost savings measures.

Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash to meet our obligations and commitments. Sources of liquidity includes, cash flows from operating activities, available borrowings under our Credit Agreement, the ability to obtain appropriate financing and our cash and cash equivalent balances. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $248.8 million during the six months ended June 30, 2020, compared to $225.9 million in the corresponding period in 2019. The increase for the six months ended June 30, 2020 benefited from the timing of working capital including strong cash collections. This was partly offset by changes in inventories during the six months ended June 30, 2020 versus the prior year comparable period as we increased inventory levels given uncertainties related to potential COVID-19 implications on our global supply chain. Cash flows provided by operating activities were also reduced by our lower net earnings as compared to the prior year period.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $37.1 million for the six months ended June 30, 2020 compared to $44.7 million in the corresponding period in 2019. We expect to make net investments in new or expanded manufacturing facilities of $15 million to $20 million over the next two years.

Senior Notes and Credit Facility Agreement

Our debt consisted of the following at June 30, 2020:

June 30, 2020 U.S. Dollar Other Principal Trading Currencies Total
3.67% $50 million ten-year Senior Notes due December 17, 2022 $50,000 $— $50,000
4.10% $50 million ten-year Senior Notes due September 19, 2023 50,000 — 50,000
3.84% $125 million ten-year Senior Notes due September 19, 2024 125,000 — 125,000
4.24% $125 million ten-year Senior Notes due June 25, 2025 125,000 — 125,000
3.91% $75 million ten-year Senior Notes due June 25, 2029 75,000 — 75,000
3.19% $50 million fifteen-year Senior Notes due January 24, 2035 50,000 — 50,000
1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030 — 140,245 140,245
1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034 — 151,464 151,464
Debt issuance costs, net (1,051) (1,105) (2,156)
Total Senior Notes 473,949 290,604 764,553
$1.1 billion Credit Agreement, interest at LIBOR plus 97.5 basis points 299,997 81,080 381,077
Other local arrangements 2,723 51,822 54,545
Total debt 776,669 423,506 1,200,175
Less: current portion (1,763) (51,822) (53,585)
Total long-term debt $774,906 $371,684 $1,146,590

As of June 30, 2020, approximately $712.1 million of additional borrowings was available under our Credit Agreement, and we maintained $127.3 million of cash and cash equivalents. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates. Further, we do not have any downgrade triggers related to ratings from rating agencies that would accelerate the maturity dates of our debt. We were in compliance with its debt covenants at June 30, 2020.

We currently believe that cash flow from operating activities, together with liquidity available under our Credit Agreement and local working capital facilities and our cash balances, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for the foreseeable future.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. During the six month ended June 30, 2019, we paid $10 million related to the settlement of the Biotix acquisition contingent consideration as further described in Note 4 of our Annual Report on Form 10-K for the year ended December 31, 2019.

In April 2018, two of our non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions which include an interest rate of Swiss franc LIBOR plus 87.5 basis points. The loans were renewed for one year in April 2020.

Share Repurchase Program

In November 2018, the Company's Board of Directors authorized an additional $2.0 billion to the share repurchase program which has $1.1 billion of remaining common shares to be repurchased under the program as of June 30, 2020. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and existing cash balances.

Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, stock price, trading restrictions, the level of acquisition activity, and other factors.

We did not repurchase any shares in the three month period ended June 20, 2020, and have purchased 28.9 million shares since the inception of the program through June 30, 2020. During the six months ended June 30, 2020 and 2019, we spent $200 million and $372.5 million on the repurchase of 268,161 and 539,326 shares at an average price per share of $745.80 and $690.66, respectively. We also reissued 114,109 shares and 226,595 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the six months ended June 30, 2020 and 2019, respectively.

Effect of Currency on Results of Operations

Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings decrease. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also decreases. We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.6 million to $1.8 million annually.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $1.7 million to $1.9 million annually.

In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Swiss franc. Based on our outstanding debt at June 30, 2020, we estimate that a 5% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $22.3 million in the reported U.S. dollar value of our debt.

Forward-Looking Statements Disclaimer

You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth and long-term impacts of the COVID-19 pandemic. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue.”

We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, customer demand, our competitive position, pricing, our supply chain, adequacy of our facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, planned research and development efforts and product introductions, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of the COVID-19 pandemic on our businesses.

Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including the uncertain duration and severity of the COVID-19 pandemic. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2019 and other reports filed with the SEC from time to time.

Market risk

As filed, 173 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of June 30, 2020, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

Controls and procedures

As filed, 703 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 3,678 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

For the three and six months ended June 30, 2020 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, except the following update.

The COVID-19 outbreak has and will likely continue to negatively affect various aspects of our business, including our workforce and supply chain, and make it more difficult and expensive to meet our obligations to our customers, and has and will likely continue to result in reduced demand from our customers as their businesses may also be negatively affected.

Our global operations are susceptible to global events that could have an adverse effect on our business results and financial condition.

For instance, we are susceptible to a widespread outbreak of an illness or other health issue, such as the ongoing 2019 Coronavirus outbreak ("COVID-19"), and which now has since spread globally, resulting in millions of confirmed cases throughout the world and in all countries where we conduct business. The outbreak has caused many governments to implement stay-at-home orders, quarantines and significant restrictions on travel. Several governments have also implemented work restrictions that prohibit many employees from going to their customary work locations and which require these employees to work remotely if possible. The quarantines, travel bans, work and other restrictions were initially put in place on a national level in China in January 2020, and with the global spread of the virus, subsequently adopted in many other countries and regions throughout the first half of 2020 with many restrictions commencing in Asia Pacific, Europe, North America and South America. Many of these restrictions remained in place during the second quarter of 2020.

As a result of pandemic outbreaks, including COVID-19, businesses can be shut down, supply chains can be interrupted, slowed, or rendered inoperable, and individuals can become ill, quarantined, or otherwise unable to work and/or travel due to health reasons or governmental restrictions. COVID-19 interferes with general commercial activity related to our supply chain and customer base. In addition, it is expected that COVID-19 will negatively affect the global economy and our customers' businesses, which will result in delayed or reduced purchases from us. Some customers may also have difficulty meeting their payment obligations to us, resulting in late payments or an inability of some customers to make payments at all.

During the three and six months ended June 30, 2020, COVID-19 had a negative impact on our business, primarily related to reduced global customer demand. We remain cautious as uncertainties related to COVID-19 and the resulting impact to the economy continues in all regions of the world and market conditions may also change quickly. With the global spread of the virus and related negative impact to the global economy, we expect reduced global sales volume from lower customer demand in future quarters. Our operations could be negatively affected further if our employees who are currently not subject to stay-at-home or work restriction orders are quarantined or become ill as a result of exposure to COVID-19, or if they become subject to governmental COVID-19 curfews or stay-at-home orders. The longer-term effects on our business will be impacted by the global economy and any recession implications in different regions of the world. While it is extremely difficult to estimate the extent and duration of any COVID-19 implications, the effects on our business, results of operations and financial condition could be material.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$690.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-30$1.34bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Gross profit3 months2020-04-01 to 2020-06-30$398.0mus-gaap:GrossProfit
Gross profit6 months2020-01-01 to 2020-06-30$772.4mus-gaap:GrossProfit
Research and development3 months2020-04-01 to 2020-06-30$31.2mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$65.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-04-01 to 2020-06-30$190.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-30$388.9mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2020-04-01 to 2020-06-30$9.6mus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$19.8mus-gaap:InterestExpense
Income tax3 months2020-04-01 to 2020-06-30$28.7mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-01 to 2020-06-30$49.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-01 to 2020-06-30$126.6mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30$224.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30$5.22us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30$9.25us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-04-01 to 2020-06-30$5.29us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-01 to 2020-06-30$9.37us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-04-01 to 2020-06-3024,228,989 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-01 to 2020-06-3024,291,321 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-01 to 2020-06-30$248.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$37.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2020-01-01 to 2020-06-30$200.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-06-30$127.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$989.8mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$2.68bnus-gaap:Assets
Current liabilitiesAt period end2020-06-30$702.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$2.23bnus-gaap:Liabilities
Long-term debtAt period end2020-06-30$1.15bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-06-30$53.6mus-gaap:DebtCurrent
Shareholders' equityAt period end2020-06-30$450.1mus-gaap:StockholdersEquity
Shares outstandingAt period end2020-06-3023,971,265 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001037646-20-000024. Last ingested by Listed: Nov 13, 2026, 02:43 ET. Listed shows no prices and gives no investment advice.